|
Madeleine presents at WITH/IN/SIGHT eventThree projects from the Koch Institute funded by the Frontier Fund where presented at this week's With/In/Sight event by the students and post-docs who led them. Monica Stanciu from the Lees Lab, Katerina Mantzavinou from the Cima lab and Madeleine from the Gertler lab all presented to a packed crowd in the KI. The fact that they all happened to be women was a bonus!
|
|
capitol hill day with metavivor foundationWhile in DC for the annual cancer research meeting, Madeleine had the incredible opportunity to go to Capitol Hill and meet with the teams of Senators from Massachusetts and California to advocate for increased NIH funding for cancer research, support for the ACA and the Right to Try Act. She joined the amazing women from the Metavivor Foundation who are battling metastatic cancer, the disease we are working so hard to cure in the lab. I was truly humbled to be with these women and am honoured to join this fight.
|
|
MADELEINE JOINS THE BIOMEDICAL ENGINEERING DEPARTMENT AT TUFTS UNIVERSITYAfter a long a busy job search, Madeleine is very excited to be joining the Biomedical Engineering Department at Tufts. She will officially start in January 2018!
|
|
FORUm piece out in Trends in Cancer!Here, we review the existing literature focusing on the use Mena isoforms as biomarkers in breast cancer. While multiple studies have demonstrated great promise for the use of these tools, there are still many open questions.
|
|
a novel role for mena in resistance to paclitaxelVery proud of this new study identifying a novel role for the actin regulator Mena in driving resistance to chemotherapeutic agent paclitaxel in metastasis disease. We show that Mena regulates microtubule dynamics, which in turn affects response to paclitaxel.
Featured on MIT news! |
|
A novel mechanisms of resistance to targeteD therapiesCheck out the MIT news piece.
|
|
|
